Ionis Drug Wins FDA Approval as First Alexander Disease Treatment
FDA approves Zanvastro from Ionis Pharmaceuticals as the first disease-modifying treatment for rare Alexander disease.
Ionis got permission from the government to sell a new medicine that actually helps people with a very rare disease called Alexander disease. This shows the company can make medicines that work, which is exciting for investors watching what the company does next.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.